Elanco Animal Health Inc (ELAN) stock
ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$26.70+0.85 (+3.29%)
Close on Nov 18, 2026Market cap $13.34BP/E –Yield –
Elanco Animal Health pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Elanco Animal Health's pe ratio was 401.3× on Jan 30, 2026, against 30.1× a year earlier. Over the last 3 years it ranged from 13.9× to 401.3×, with a median of 106.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 401.3× | +24.2 |
| 2025 | Dec 31, 2025 | 377.2× | +346.9 |
| 2024 | Dec 31, 2024 | 30.3× | −107.0 |
| 2020 | Apr 30, 2020 | 137.3× | +24.0 |
| 2019 | Dec 31, 2019 | 113.3× | – |
See a number that looks wrong?